These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 32281550)

  • 1. Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries.
    Horisawa K; Suzuki A
    Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(4):131-158. PubMed ID: 32281550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
    Xie M; Tang S; Li K; Ding S
    Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Cellular Reprogramming: The Next Generation.
    Srivastava D; DeWitt N
    Cell; 2016 Sep; 166(6):1386-1396. PubMed ID: 27610565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
    Sadahiro T; Yamanaka S; Ieda M
    Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct reprogramming into desired cell types by defined factors.
    Ieda M
    Keio J Med; 2013; 62(3):74-82. PubMed ID: 23801083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular roadblocks for cellular reprogramming.
    Vierbuchen T; Wernig M
    Mol Cell; 2012 Sep; 47(6):827-38. PubMed ID: 23020854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering Cell Fate for Tissue Regeneration by In Vivo Transdifferentiation.
    de Lázaro I; Kostarelos K
    Stem Cell Rev Rep; 2016 Feb; 12(1):129-39. PubMed ID: 26403511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative Medicine.
    Burridge PW; Sharma A; Wu JC
    Annu Rev Genet; 2015; 49():461-84. PubMed ID: 26631515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial reprogramming as a therapeutic approach for heart disease: A state-of-the-art review.
    Talkhabi M
    J Cell Biochem; 2019 Sep; 120(9):14247-14261. PubMed ID: 31081174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Direct Reprogramming of Mouse and Human Astrocytes to Induced Neurons.
    Aravantinou-Fatorou K; Thomaidou D
    Methods Mol Biol; 2020; 2155():41-61. PubMed ID: 32474866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A blueprint for engineering cell fate: current technologies to reprogram cell identity.
    Morris SA; Daley GQ
    Cell Res; 2013 Jan; 23(1):33-48. PubMed ID: 23277278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo reprogramming for tissue regeneration and organismal rejuvenation.
    Taguchi J; Yamada Y
    Curr Opin Genet Dev; 2017 Oct; 46():132-140. PubMed ID: 28779646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct cellular reprogramming techniques for cardiovascular regenerative therapeutics.
    He X; Dutta S; Liang J; Paul C; Huang W; Xu M; Chang V; Ao I; Wang Y
    Can J Physiol Pharmacol; 2024 Jan; 102(1):1-13. PubMed ID: 37903419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming fibroblasts toward cardiomyocytes, neural stem cells and hepatocytes by cell activation and signaling-directed lineage conversion.
    Zhu S; Wang H; Ding S
    Nat Protoc; 2015 Jul; 10(7):959-73. PubMed ID: 26042385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct reprogramming of mouse fibroblasts into cardiac myocytes.
    Inagawa K; Ieda M
    J Cardiovasc Transl Res; 2013 Feb; 6(1):37-45. PubMed ID: 23054660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical compound-based direct reprogramming for future clinical applications.
    Takeda Y; Harada Y; Yoshikawa T; Dai P
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29739872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
    Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
    Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion.
    Kwon D; Ji M; Lee S; Seo KW; Kang KS
    Stem Cell Rev Rep; 2017 Feb; 13(1):24-34. PubMed ID: 27817181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming lineage identity through cell-cell fusion.
    Brown KE; Fisher AG
    Curr Opin Genet Dev; 2021 Oct; 70():15-23. PubMed ID: 34087754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic reprogramming of cell identity: lessons from development for regenerative medicine.
    Basu A; Tiwari VK
    Clin Epigenetics; 2021 Jul; 13(1):144. PubMed ID: 34301318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.